跳至主要内容
临床试验/NCT02383654
NCT02383654已完成1 期

An Exploratory Clinical Trial to Assess Treatment of Amyotrophic Lateral Sclerosis With Brain Transplants of Autologous Adipose-Tissue Derived Stem Cells (ADSCs)

China Medical University Hospital1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2015年1月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
1
试验地点
1
主要终点
changes of ALS-FRS score

研究概览

简要总结

The purpose of the study is to determine the safety and possible effectiveness of Autologous Adipose-Tissue Derived Stem Cells treatment in a Amyotrophic Lateral Sclerosis(ALS) patient.

详细描述

This pilot clinical trial is design to see the safety and possible efficiency of ADSCs treatment in a ALS patient. one subjects will be treated (n=1). The patient will receive brain transplantation of ADSCs and combines intravenous infusion ADSCs 4 times. Subjects will be assessed by adverse effects and functional outcomes of clinical: PI max , PE max,and Haloscale respiration, ALS functional rating scale (ALS-FRS) are analyzed at 1 month, 3 months, 6 months 9 months and 12 months.

Brain MRI scans will be obtained before and after the treatment. Long term follow-up will be performed at 1, 6 , and 12months for safety reasons. Brain CT for check operation safety before and after brain implantation.

Timing of Study: 12months recruitment period after approvals

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
35 Years 至 50 Years(Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •Compassionate Treatment
  • •The number of participants for a person.
  • •The patients (Guo XX) of 28% of lung function assessment (normal lung function was greater than 80%), the daily life of motor function score was 17 points (normal function score of 40 points).

排除标准

  • 未提供

研究组 & 干预措施

Compassionate Treatment

Other

ALS patients are received Intravenous and intracerebral implantation of Autologous Adipose-Tissue Derived Stem Cells (ADSCs), Rehabilitation.

干预措施: Autologous Adipose-Tissue Derived Stem Cells (Procedure)

结局指标

主要结局

changes of ALS-FRS score

时间窗: Baseline-Day 28-Day 44-Day 60-6 months-9months-12months

using ALS-FRS score to assess patient's function after transplantation.

changes of respiratory function

时间窗: Baseline-Day 28-Day 44-Day 60-6 mouths-9mouths-12mouths

check the changes of respiratory functions after intervention .

changes of neurologic function

时间窗: Baseline-Day 28-Day 44-Day 60-6 mouths-9mouths-12mouths

check any changes of neurologic functions after intervention .

次要结局

  • changes of brain structure(Baseline-Day 60- 6 mounths-12 mounths)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shinn-Zong Lin

Superintendent, China Medical University Beigang Hospital, Taiwan

China Medical University Hospital

研究点 (1)

Loading locations...

相似试验